These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5657231)

  • 41. New angiotensin-II blocker.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
    [No Abstract]   [Full Text] [Related]  

  • 42. [Stroke prevention. Is there an added value to RAS inhibition?].
    MMW Fortschr Med; 2000 Feb; 142(6):62-3. PubMed ID: 10832360
    [No Abstract]   [Full Text] [Related]  

  • 43. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of glaucoma with catapresan].
    Honegeer H; Wachholz E
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):306-7. PubMed ID: 5555611
    [No Abstract]   [Full Text] [Related]  

  • 45. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

  • 46. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment with hypertension with catapresan].
    Votchal BE; Kuchkina TS; Abramova VG
    Vrach Delo; 1972 Sep; 9():21-4. PubMed ID: 4658108
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H
    Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 51. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
    Zimlichman R
    Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
    [No Abstract]   [Full Text] [Related]  

  • 52. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance of catapresan in the antihypertensive treatment of late gestoses].
    Gerlach E
    Med Monatsschr; 1968 Oct; 22(10):461-6. PubMed ID: 5712739
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
    Gurevich MA
    Klin Med (Mosk); 2002; 80(9):9-13. PubMed ID: 12416217
    [No Abstract]   [Full Text] [Related]  

  • 56. Moxonidine improves glycaemic control in mildly hypertensive, overweight type 2 diabetic patients.
    Cardiovasc J Afr; 2007; 18(4):271. PubMed ID: 17940677
    [No Abstract]   [Full Text] [Related]  

  • 57. [Behavior of psyche, blood pressure and pulse rate following administration of the antihypertensive agent "Catapresan"].
    Steinbach M
    Med Welt; 1967 Feb; 8():456-8. PubMed ID: 6044570
    [No Abstract]   [Full Text] [Related]  

  • 58. [The use of catapresan in the treatment of arterial hypertension].
    Teodorescu P; Cîmpeanu A
    Med Interna (Bucur); 1970 Dec; 22(12):1475-86. PubMed ID: 5502468
    [No Abstract]   [Full Text] [Related]  

  • 59. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.
    Schachter M; Mitchell G; Niziol C; Abhyankar BA
    Int J Clin Pract; 2003; 57(6):479-82. PubMed ID: 12918886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.